Cornerstone Capital Management Holdings’s Acceleron Pharma XLRN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$724K	Sell	17,083 -3,800	-18%	-$143K	0.01%	954
2017 Q3	$778K	Sell	20,883 -9,700	-32%	-$337K	0.01%	979
2017 Q2	$929K	Buy	30,583 +11,624	+61%	+$337K	0.01%	923
2017 Q1	$501K	Buy	+18,959	New	+$500K	﹤0.01%	1061
2016 Q4	–	Sell	-300	Closed	-$10K	–	1447
2016 Q3	$10K	Buy	+300	New	+$9.94K	﹤0.01%	1339
2016 Q1	–	Sell	-200	Closed	-$10K	–	1589
2015 Q4	$10K	Buy	+200	New	+$7.2K	﹤0.01%	1427
2015 Q2	–	Sell	-5,200	Closed	-$198K	–	1503
2015 Q1	$198K	Buy	+5,200	New	+$207K	﹤0.01%	1181

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Cornerstone Capital Management Holdings's XLRN Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Acceleron Pharma (XLRN) stake by 18% in Q4 2017, selling an estimated $143K and leaving 17,083 shares worth $724K. The position accounts for 0.01% of the portfolio, ranked #954.

Cornerstone Capital Management Holdings first reported a position in XLRN in Q1 2015 and has held it in 7 quarters since. The position peaked at $929K in Q2 2017. 137 funds tracked by Wall St. Rank hold XLRN as of Q4 2017.

Cornerstone Capital Management Holdings held 17,083 shares of Acceleron Pharma worth $724K as of Q4 2017.
Cornerstone Capital Management Holdings sold 3,800 Acceleron Pharma shares in Q4 2017, an estimated $143K.
Acceleron Pharma made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #954 holding.
Cornerstone Capital Management Holdings first reported a position in Acceleron Pharma in Q1 2015 and has held it in 7 quarters since.
Cornerstone Capital Management Holdings's Acceleron Pharma position peaked at $929K in Q2 2017.
137 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.